Answer
Antibodies against the protein components of Curosurf (poractant alfa) have been observed, but no evidence of clinical relevance has been demonstrated so far.
Sources for this answer
- CurosurfChiesi Limited · emc · SmPC §4.8 Undesirable effects · Version 7Document updated
Sources checked